肝豆状核变性与慢性乙型肝炎重度患者临床特征分析*

doi:10.3969/j.issn.1672-5069.2015.05.010

实用肝脏病杂志 ›› 2015, Vol. 18 ›› Issue (5): 486-490.doi: 10.3969/j.issn.1672-5069.2015.05.010

肝豆状核变性与慢性乙型肝炎重度患者临床特征分析^*

陈韬，叶昊，方文敏，吴亮，黄元成

430030 武汉市华中科技大学同济医学院附属同济医院感染病科（陈韬，吴亮，黄元成）；湖北省京山县人民医院感染病科（叶昊）；湖北省咸宁市中心医院感染病科（方文敏）

收稿日期:2015-04-03 出版日期:2015-09-10 发布日期:2016-02-18
通讯作者: 黄元成，E-mail：tjhych@sohu.com E-mail:chentao_tjh@vip.sina.com
作者简介:陈韬，男，36岁，博士研究生，主治医师。主要从事肝脏疾病及感染性疾病诊断与治疗学研究。E-mail：chentao_tjh@vip.sina.com
基金资助:
华中科技大学自主创新基金重点项目（编号：2013ZHYX004)

Clinical features of patients with Wilson’s disease and hyperbilirubinemia: Comparison to patients with chronic hepatitis B of severe degree

Chen Tao, Ye Hao, Fang Wenmin, et al.

Institute of Infectious Disease, Tongji Hospital， Tongji Medical College， Huazhong University of Science and Technology， Wuhan 430030， Hubei Province， China

Received:2015-04-03 Online:2015-09-10 Published:2016-02-18

摘要/Abstract

摘要： 目的观察肝豆状核变性（WD）伴黄疸患者的临床特征，探讨肝豆状核变性黄疸患者临床鉴别诊断的侧重点。方法回顾性分析52例以“黄疸待查”初次入院的WD患者的临床资料，包括临床表现和常规实验室指标的变化。采用序列分析法检测全血基因组8、12、13、16外显子的突变情况。结果本研究纳入WD患者24例和慢性乙型肝炎重度患者28例。WD患者发病中位年龄（33.2岁）显著低于乙型肝炎（41.8岁，P=0.049），WD患者自起病至明确诊断的中位时间（8.2月）显著长于乙型肝炎（1月，P<0.001）；WD患者24 h尿铜水平（919.83±1017.15 μg）显著高于乙型肝炎（204.79±191.85 μg，P<0.001）；WD患者血清γ-谷氨酰转肽酶水平（175.74±245.99 U/L）显著高于乙型肝炎（133.44±115.95 U/L，P=0.004），且与24 h尿铜水平呈正相关（r=0.552，P=0.012）；24例WD患者全部，而仅4例乙型肝炎患者可检出ATP7B突变。结论肝豆状核变性伴黄疸患者除可利用血清铜、铜蓝蛋白检测进行筛选性诊断外，24 h尿铜检测为重要的鉴别诊断指标，而血清γ-谷氨酰转肽酶可能是该病潜在的诊断指标。

关键词: 肝豆状核变性, 黄疸, 临床特征, 鉴别诊断

Abstract: Objective To explore the clinical features of patients with Wilson’s disease and hyperbilirubinemia. Method Twenty-four patients with Wilson’s disease and twenty-eight with chronic hepatitis B of severe degree were included in this study. The manifestation and routine laboratory tests were collected. The peripheral blood ATP7B gene mutations in exon 8， 12， 13 and 16 were analyzed by direct sequencing. Results The patients with WD had the features of significantly younger（33.2 vs. 41.8 yr old，P=0.049），longer delay diagnosis time（8.2 vs. 1 month，P<0.001） as compared to patients with hepatitis B；the total urine copper in 24 hours was significantly elevated [（919.83±1017.15） μg vs. （204.79±191.85） μg，P<0.001]；the patients with WD had significantly higher serum glutamyltranspeptidase level [（175.74±245.99） U/L] as compared with in patients with hepatitis B[（133.44±115.95） U/L，P=0.004]，which had a positive correlation with 24 hours total urine copper drainage（r=0.552，P=0.012）；all the patients with WD were positive for ATP7B mutation，while only 4 patients with hepatitis B positive. Conclusion Serum copper and ceruloplasmin levels may be useful for screening patients with WD and jaundice，and the 24 hour urine copper excretion is an important index for differential diagnosis from severe chronic hepatitis B.

Key words: Wilson’s Disease, Hyperbilirubinemia, Clinical features, Differential diagnosis

陈韬，叶昊，方文敏，吴亮，黄元成. 肝豆状核变性与慢性乙型肝炎重度患者临床特征分析^*[J]. 实用肝脏病杂志, 2015, 18(5): 486-490.

Chen Tao, Ye Hao, Fang Wenmin, et al.. Clinical features of patients with Wilson’s disease and hyperbilirubinemia: Comparison to patients with chronic hepatitis B of severe degree[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 486-490.

参考文献

[1] Roberts EA，Schilsky ML. American Association for Study of Liver Diseases （AASLD）. Diagnosis and treatment of Wilson disease:an update. Hepatology，2008，47（6）:2089-2111.
[2] Medici V，Rossaro L，Sturniolo GC. Wilson disease–a practical approach to diagnosis， treatment and follow-up. Dig Liver Dis，2007，39（7）:601-609.
[3] Shah D. Wilson's disease:hepatic manifestations. Dis Mon， 2014，60（9）:465-474.
[4] Dalvi A. Wilson's disease:neurological and psychiatric manifestations. Dis Mon，2014，60（9）:460-464.
[5] Dalvi A，Padmanaban M. Wilson's disease:etiology，diagnosis， and treatment. Dis Mon，2014，60（9）:450-459.
[6] Schilsky ML. Wilson disease:current status and the future. Biochimie，2009，91（10）:1278-1281.
[7] Ala A，Schilsky ML. Wilson disease:pathophysiology，diagnosis，treatment，and screening. Clin Liver Dis，2004，8（4）:787-805，viii.
[8] 中华医学会神经病学分会帕金森病及运动障碍学组，中华医学会神经病学分会神经遗传病学组．肝豆状核变性的诊断与治疗指南.中华神经科杂志，2008，41（8）∶566-569.
[9] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志，2011，14（2）：81-89.
[10] Liu Y，Zhou H，Guo H，et al. Genetic and clinical analysis in a cohort of patients with Wilson's Disease in Southwestern China. Arch Med Res，2015，19. pii:S0188-4409.
[11] Zhvania ML，Gogberashvili KL，Gagoshidze M，et al. Wilson disease with thrombocytopenia（case report）. Georgian Med New，2014，237:61-64.
[12] Bari Z，Saltik Tem zel IN，Uslu N，et al. Acute liver failure in children:20-year experience. Turk J Gastroenterol，2012，23（2）:127-134.
[13] Kang KS. Abnormality on liver function test. Pediatr Gastroenterol Hepatol Nutr，2013，16（4）:225-232.
[14] Bandmann O，Weiss KH，Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol，2015，14（1）:103-113.
[15] Alexandrova A，Kebis A，Misl'anová C，et al. Copper impairsbiliary epithelial cells and induces protein oxidation and oxidative DNA damage in the isolated perfused rat liver. Exp Toxicol Pathol，2007，58（4）:255-261.
[16] Wu F，Wang J，Pu C，et al. Wilson's Disease: a comprehensive review of the molecular mechanisms. Int J Mol Sci，2015，16（3）: 6419-6431.
[17] Braiterman LT，Murthy A，Jayakanthan S，et al. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B. Proc Natl Acad Sci U S A，2014，111（14）:E1364-1373.
[18] Ferenci P. Phenotype-genotype correlations in patients with Wilson's disease. Ann N Y Acad Sci，2014，1315:1-5.
[19] Gu YH，Kodama H，Du SL，et al. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson′s disease. Clin Genet，2003，64（6）:479-484.
[20] Wei Z，Huang Y，Liu A，et al. Mutational characterization of ATP7B gene in 103 Wilson's disease patients from Southern China:identification of three novel mutations. Neuroreport，2014，25（14）:1075-1080.
[21] 刘芸野，谷雷雷，黄道，等. 肝豆状核变性的临床特征及其分子诊断. 诊断学理论与实践，2014，13（3）：267-270.

肝豆状核变性与慢性乙型肝炎重度患者临床特征分析^*

Clinical features of patients with Wilson’s disease and hyperbilirubinemia: Comparison to patients with chronic hepatitis B of severe degree

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴欣, 郭杨志, 杜霄壤, 吴孟晋, 朱云, 冯兴中. 75例中药诱导的肝损伤患者临床特征分析*[J]. 实用肝脏病杂志, 2019, 22(5): 668-671.
[2]	乔志忠. 超声造影定量分析鉴别肝脏局灶性结节性增生与原发性肝癌初步探讨[J]. 实用肝脏病杂志, 2019, 22(3): 421-424.
[3]	黄文荣, 王慧, 李小华. 不同肝胆疾病患者胆囊CT表现分析[J]. 实用肝脏病杂志, 2019, 22(3): 445-448.
[4]	蒋奕,刘冰. 慢性乙型肝炎与慢性丙型肝炎患者临床和肝组织病理学特征分析[J]. 实用肝脏病杂志, 2019, 22(2): 188-191.
[5]	宋芳娇,朱冰,吕飒,田华,王海波,辛绍杰,游绍莉. 314例药物性肝衰竭患者临床特征分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 216-219.
[6]	郭宝娜, 展玉涛. 酒精性肝病79例临床特征分析[J]. 实用肝脏病杂志, 2018, 21(6): 877-880.
[7]	曹海霞, 范建高. 欧洲儿童肝豆状核变性诊疗推荐意见简介[J]. 实用肝脏病杂志, 2018, 21(4): 502-504.
[8]	纪元. 隐源性非硬化性门脉高压症患者临床和肝组织病理学表现[J]. 实用肝脏病杂志, 2018, 21(3): 325-328.
[9]	郭严, 陈东风, 文良志. 肝前性黄疸的诊断与治疗[J]. 实用肝脏病杂志, 2018, 21(2): 157-159.
[10]	杨敏, 卢明芹. 肝细胞性黄疸的诊断与治疗[J]. 实用肝脏病杂志, 2018, 21(2): 160-162.
[11]	张勋, 孙秋林, 李家斌. 散发性戊型肝炎156例临床分析[J]. 实用肝脏病杂志, 2017, 20(6): 705-708.
[12]	肖蕾, 王金萍, 张靖, 王佳佳. ARFI技术与红细胞参数评价肝豆状核变性患者肝组织纤维化程度的效能研究[J]. 实用肝脏病杂志, 2017, 20(6): 724-727.
[13]	韩彦青，叶飘，石境懿. 低出生体质量胆汁淤积儿临床特征和结局随访研究[J]. 实用肝脏病杂志, 2017, 20(5): 588-591.
[14]	黄艳艳，林书典，詹锋，何周桃. 狼疮性肝损伤患者临床特征调查[J]. 实用肝脏病杂志, 2017, 20(5): 610-611.
[15]	徐秀红，姜赛龙，蒋春兰. 超声弹性成像与常规超声诊断肝脏局灶性良恶性病变价值比较[J]. 实用肝脏病杂志, 2017, 20(5): 629-630.